Platelet vitamin D receptor is reduced in osteoporotic patients

Panminerva Medica

Volumn 54, Issue 3, 2012, Pages 225-231

  D'Amelio, P ^a   Cristofaro, M A ^a   De Vivo, E ^b   Ravazzoli, M ^a   Grosso, E ^c   Bella, S D I ^a   Aime, M ^b   Cotto, N ^b   Silvagno, F ^b   Isaia, G ^a   Pescarmona, G P ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c CTO HOSPITAL   (Italy)

Author keywords

Blood platelets; Menopause; Osteoporosis; Vitamin d

Indexed keywords

CALCITRIOL RECEPTOR; PHOSPHORUS; VITAMIN D;

ADULT; AGED; ARTICLE; BONE; BONE DENSITY; CYTOLOGY; DOSE RESPONSE; FEMALE; FEMUR FRACTURE; HUMAN; MALE; METABOLISM; MIDDLE AGED; OSTEOPOROSIS; THROMBOCYTE;

ADULT; AGED; BLOOD PLATELETS; BONE AND BONES; BONE DENSITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEMORAL FRACTURES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PHOSPHORUS; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 84867157519     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Norman AW, Olivera CJ, Barreto Silva FR and Bishop JE. A specific binding protein/receptor for lalpha,25-dihydroxyvitamin D(3) is present in an intestinal caveolae membrane fraction. Biochem Biophys Res Commun 2002;298:49414-9.
2. Norman AW, Mizwicki MT, Norman DP. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 2004;3:4827-41.
3. Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 2006;147:445542-8.
4. Demay MB, Kiernan MS, DeLuca HF, Kronenberg HM. Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1992;89:518097-101.
5. Halloran BP, DeLuca HF. Appearance of the intestinal cytosolic receptor for 1,25-dihydroxyvitamin D3 during neonatal development in the rat. J Biol Chem 1981;256:527338-42.
6. Dokoh S, Donaldson CA, Haussler MR. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25- dihydroxyvitamin D3 receptor. Cancer Res 1984;44:532103-9.
7. Healy KD, Vanhooke JL, Prahl JM, DeLuca HF. Parathyroid hormone decreases renal vitamin D receptor expression in vivo. Proc Natl Acad Sci USA 2005;102:584724-8.
8. Healy KD, Frahm MA, DeLuca HF. 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization. Arch Biochem Biophys 2005;433:59466-73.
9. Sandgren ME, DeLuca HF. Serum calcium and vitamin D regulate 1,25-dihydroxyvitamin D3 receptor concentration in rat kidney in vivo. Proc Natl Acad Sci USA 1990;87:554312-4.
10. Costa EM, Feldman D. Homologous up-regulation of the 1,25 (OH)2 vitamin D3 receptor in rats. Biochem Biophys Res Commun 1986;137:57742-7.
11. Dusso AS. Vitamin D receptor: mechanisms for vitamin D resistance in renal failure. Kidney Int Suppl 2003;62S6-9.
12. Ryan P, Dixon T. Prevalence of vitamin D inadequacy in patients attending a metabolic bone clinic in Medway. Curr Med Res Opin 2006;22:46211-6.
13. Venning G. Recent developments in vitamin D deficiency and muscle weakness among elderly people. Bmj 2005;330:76524-6.
14. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:312257-64.
15. Jackson C, Gaugris S, Sen SS, Hosking D. The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis. Qjm 2007;100:33185-92.
16. Grundberg E, Lau EM, Pastinen T, Kindmark A, Nilsson O, Ljunggren O et al. Vitamin D receptor 3' haplotypes are unequally expressed in primary human bone cells and associated with increased fracture risk: the MrOS Study in Sweden and Hong Kong. J Bone Miner Res 2007;42.
17. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:37284-7.
18. Thakkinstian A., D'Este; C., Eisman J., Nguyen T., Attia J. Metaanalysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res 2004;19:39419-28.
19. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004;338:41143-56.
20. Song LN. Demonstration of vitamin D receptor expression in a human megakaryoblastic leukemia cell line: regulation of vitamin D receptor mRNA expression and responsiveness by forskolin. J Steroid Biochem Mol Biol 1996;57:68265-74.
21. Silvagno F, De Vivo E, Attanasio A, Gallo V, Mazzucco G, Pescarmona G. Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes. PLoS One 5:78e8670.
22. Silvagno F, Poma CB, Realmuto C, Ravarino N, Ramella A, Santoro N et al. Analysis of vitamin D receptor expression and clinical correlations in patients with ovarian cancer. Gynecol Oncol 119:77121-4.
23. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. who study group. Osteoporos Int 1994;4:0368-81.
24. D'Amelio P, Tamone C, Pluviano F, Di Stefano M, Isaia G. Effects of lifestyle and risk factors on bone mineral density in a cohort of Italian women: suggestion for a new decision rule. Calcif Tissue Int 2005;77:072-8.
25. Favus MJ, Karnauskas AJ, Parks JH, Coe FL. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab 2004;89:264937-43.
26. D'Amelio P., Grimaldi A., Cristofaro M.A., Ravazzoli M., Molinatti P.A., Pescarmona G.P., Isaia G.C. Alendronate reduces osteoclast precursors in osteoporosis. Osteoporos Int 2010;21:791741-50.
27. Sone T, McDonnell DP, O'Malley BW, Pike JW. Expression of human vitamin D receptor in Saccharomyces cerevisiae. Purification, properties, and generation of polyclonal antibodies. J Biol Chem 1990;265:2821997-2003.
28. Michaelsson K, Melhus H, Ferm H, Ahlbom A, Pedersen NL. Genetic liability to fractures in the elderly. Arch Intern Med 2005;165:381825-30.
29. Ralston SH. Genetics of osteoporosis. Proc Nutr Soc 2007; 66: 67158-65.
30. Ross TK, Darwish HM, DeLuca HF. Molecular biology of vitamin D action. Vitam Horm 1994;49:54281-326.
31. Yates AA, Schlicker SA, Suitor CW. Dietary reference intakes: the new basis for recommendations for calcium and related nutrients, B vitamins, and choline. J Am Diet Assoc 1998;98:71699-706.
32. Looker AC, Mussolino ME. Serum 25-hydroxyvitamin d and hip fracture risk in older U.S. white adults. J Bone Miner Res 2008;23:72143-50.
33. Aihara K, Azuma H, Akaike M, Ikeda Y, Yamashita M, Sudo T et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 2004;279:6135798-802.
34. Gonzalez Pardo V, Boland R, de Boland AR. Vitamin D receptor levels and binding are reduced in aged rat intestinal subcellular fractions. Biogerontology 2007;74.